These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 21785747)
1. Therapeutic target achievement in type 2 diabetic patients after hyperglycemia, hypertension, dyslipidemia management. Kang AY; Park SK; Park SY; Lee HJ; Han Y; Lee SR; Suh SH; Kim DK; Park MK Diabetes Metab J; 2011 Jun; 35(3):264-72. PubMed ID: 21785747 [TBL] [Abstract][Full Text] [Related]
2. Importance of measuring non-HDL cholesterol in type 2 diabetes patients. Ram N; Ahmed B; Hashmi F; Jabbar A J Pak Med Assoc; 2014 Feb; 64(2):124-8. PubMed ID: 24640797 [TBL] [Abstract][Full Text] [Related]
3. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients. Ji L; Hu D; Pan C; Weng J; Huo Y; Ma C; Mu Y; Hao C; Ji Q; Ran X; Su B; Zhuo H; Fox KA; Weber M; Zhang D; ; Am J Med; 2013 Oct; 126(10):925.e11-22. PubMed ID: 23810406 [TBL] [Abstract][Full Text] [Related]
4. Achievement of national clinical practice recommendations among those in the Puerto Rican population with diabetes mellitus. Rodríguez-Vigil E; Rodríguez-Chacón M; Trabanco C; Irizarry-Ramos J P R Health Sci J; 2014 Dec; 33(4):157-62. PubMed ID: 25563032 [TBL] [Abstract][Full Text] [Related]
5. Effect of glycemic and lipid achievements on clinical outcomes type 2 diabetic, Chinese patients with stable coronary artery disease. Li S; Zhang Y; Guo YL; Zhu CG; Wu NQ; Qing P; Gao Y; Sun J; Liu G; Dong Q; Li JJ J Diabetes Complications; 2016; 30(1):115-20. PubMed ID: 26481154 [TBL] [Abstract][Full Text] [Related]
6. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T; Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481 [TBL] [Abstract][Full Text] [Related]
7. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus. Udawat H; Goyal RK Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472 [TBL] [Abstract][Full Text] [Related]
8. The Status of Metabolic Control in Patients With Type 2 Diabetes Attending Dasman Diabetes Institute, Kuwait. Qaddoumi M; Al-Khamis Y; Channanath A; Tuomilehto J; Badawi D Front Endocrinol (Lausanne); 2019; 10():412. PubMed ID: 31297092 [No Abstract] [Full Text] [Related]
9. [Diabetes control in type 2 diabetic subjects treated in primary health care--how far is from life to standards?]. Fabian W; Majkowska L; Stefański A; Moleda P Przegl Lek; 2008; 65(6):277-82. PubMed ID: 18853658 [TBL] [Abstract][Full Text] [Related]
10. Achievement of guideline targets of glycemic and non-glycemic parameters in North Indian type 2 diabetes mellitus patients: A retrospective analysis. Ashraf H; Faraz A; Ahmad J Diabetes Metab Syndr; 2021; 15(1):425-431. PubMed ID: 33588199 [TBL] [Abstract][Full Text] [Related]
11. Assessment of Achievement of American Diabetes Association (ADA) Targets in Patients with Type 2 Diabetes Mellitus at a Tertiary Care Centre in Eastern Nepal. Baranwal JK; Maskey R; Chaudhari RK; Sherchand O Diabetes Metab Syndr Obes; 2020; 13():2959-2964. PubMed ID: 32943892 [TBL] [Abstract][Full Text] [Related]
12. Status of lipid-lowering therapy prescribedbased on recommendations in the 2002 report of the Japan Atherosclerosis Society Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults: A study of the Japan Lipid Assessment Program (J-LAP). Teramoto T; Kashiwagi A; Mabuchi H; J-Lap Investigators Curr Ther Res Clin Exp; 2005 Mar; 66(2):80-95. PubMed ID: 24672115 [TBL] [Abstract][Full Text] [Related]
13. Achievements of Diabetes Goals and Their Determinants in Type 2 Diabetic Patients Attending Outpatient Diabetic Clinic in Northern Ethiopia. Belay E; Abera A; Mehari A; Gebremeskel G; Endrias A; Endris K Int J Chronic Dis; 2017; 2017():5713187. PubMed ID: 29464189 [TBL] [Abstract][Full Text] [Related]
14. Managing type 2 diabetes: going beyond glycemic control. Stolar MW; Hoogwerf BJ; Gorshow SM; Boyle PJ; Wales DO J Manag Care Pharm; 2008 Jun; 14(5 Suppl B):s2-19. PubMed ID: 18597582 [TBL] [Abstract][Full Text] [Related]
15. Impact of obtaining medications from pharmaceutical company assistance programs on therapeutic goals. Trompeter JM; Havrda DE Ann Pharmacother; 2009 Mar; 43(3):469-77. PubMed ID: 19240259 [TBL] [Abstract][Full Text] [Related]
16. Association of Dyslipidemia with Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients: A Hospital-Based Study. Ezhilvendhan K; Sathiyamoorthy A; Prakash BJ; Bhava BS; Shenoy A J Pharm Bioallied Sci; 2021 Nov; 13(Suppl 2):S1062-S1067. PubMed ID: 35017930 [TBL] [Abstract][Full Text] [Related]
17. Pharmacologic treatment of type 2 diabetic dyslipidemia. Moon YS; Kashyap ML Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439 [TBL] [Abstract][Full Text] [Related]
18. Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals. Meloni AR; DeYoung MB; Han J; Best JH; Grimm M Cardiovasc Diabetol; 2013 Mar; 12():48. PubMed ID: 23522121 [TBL] [Abstract][Full Text] [Related]
19. Glycemic control and diabetic dyslipidemia in adolescents with type 2 diabetes. Le PT; Huisingh CE; Ashraf AP Endocr Pract; 2013; 19(6):972-9. PubMed ID: 23807519 [TBL] [Abstract][Full Text] [Related]
20. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices. Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]